Response to the Letter by Singh et al Regarding “Apolipoprotein Isoform E4 Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.